These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33321758)

  • 1. Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A
    Najahi-Missaoui W; Quach ND; Somanath PR; Cummings BS
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion.
    Najahi-Missaoui W; Quach ND; Jenkins A; Dabke I; Somanath PR; Cummings BS
    Pharmacol Res Perspect; 2019 Oct; 7(5):e00518. PubMed ID: 31516713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.
    Mock JN; Costyn LJ; Wilding SL; Arnold RD; Cummings BS
    Integr Biol (Camb); 2013 Jan; 5(1):172-82. PubMed ID: 22890797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo.
    Al-Azayzih A; Missaoui WN; Cummings BS; Somanath PR
    Nanomedicine; 2016 Jul; 12(5):1231-1239. PubMed ID: 26949163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A
    Verma A; Najahi-Missaoui W; Cummings BS; Somanath PR
    Oncol Lett; 2020 Nov; 20(5):179. PubMed ID: 32934746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the use of sPLA
    Pourhassan H; Clergeaud G; Hansen AE; Østrem RG; Fliedner FP; Melander F; Nielsen OL; O'Sullivan CK; Kjær A; Andresen TL
    J Control Release; 2017 Sep; 261():163-173. PubMed ID: 28662900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
    Quach ND; Mock JN; Scholpa NE; Eggert MW; Payré C; Lambeau G; Arnold RD; Cummings BS
    Mol Pharm; 2014 Oct; 11(10):3443-51. PubMed ID: 25189995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory phospholipase (sPLA
    Mehta D; Shaikh S; Mohanty B; Chaudhari P; Waghmare SK
    Biochem Biophys Res Commun; 2023 Oct; 677():98-104. PubMed ID: 37566923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells.
    Shemesh CS; Hardy CW; Yu DS; Fernandez B; Zhang H
    Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):193-203. PubMed ID: 24657627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleanolic acid protects against cognitive decline and neuroinflammation-mediated neurotoxicity by blocking secretory phospholipase A2 IIA-activated calcium signals.
    Zhang L; Xia R; Jia J; Wang L; Li K; Li Y; Zhang J
    Mol Immunol; 2018 Jul; 99():95-103. PubMed ID: 29747052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory phospholipase A
    Østrem RG; Parhamifar L; Pourhassan H; Clergeaud G; Nielsen OL; Kjær A; Hansen AE; Andresen TL
    J Control Release; 2017 Sep; 262():212-221. PubMed ID: 28754610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells.
    Kuželová K; Grebeňová D; Holoubek A; Röselová P; Obr A
    PLoS One; 2014; 9(3):e92560. PubMed ID: 24664099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
    Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM
    PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory phospholipase A2 mediates human esophageal adenocarcinoma cell growth and proliferation via ERK 1/2 pathway.
    Sadaria MR; Yu JA; Meng X; Fullerton DA; Reece TB; Weyant MJ
    Anticancer Res; 2013 Apr; 33(4):1337-42. PubMed ID: 23564770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
    Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
    Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
    Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
    World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid droplets induced by secreted phospholipase A
    Jarc E; Kump A; Malavašič P; Eichmann TO; Zimmermann R; Petan T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Mar; 1863(3):247-265. PubMed ID: 29229414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer.
    Dai W; Yang F; Ma L; Fan Y; He B; He Q; Wang X; Zhang H; Zhang Q
    Biomaterials; 2014 Jul; 35(20):5347-5358. PubMed ID: 24726747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids.
    Jensen SS; Andresen TL; Davidsen J; Høyrup P; Shnyder SD; Bibby MC; Gill JH; Jørgensen K
    Mol Cancer Ther; 2004 Nov; 3(11):1451-8. PubMed ID: 15542784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.